Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokeratins and tissue polypeptide antigen

B E Sundström1, T I Stigbrand

  • 1AB Sangtec Medical, Bromma, Sweden.

The International Journal of Biological Markers
|April 1, 1994
PubMed
Summary

Cytokeratins (CKs) are structural proteins in epithelial cells. Certain CKs, like CK 8, 18, and 19, are valuable tumor markers for cancer diagnosis and monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2000
Same author

A putative mechanism for the non-specific uptake of intact radiolabelled monoclonal antibodies in the testes and prostate.

Acta oncologica (Stockholm, Sweden)·1996
Same author

Development of a new Prolifigen TPA IRMA assay using monoclonal anti-cytokeratin antibodies.

The International journal of biological markers·1995
Same author

The human placental immunoglobulin G receptor and immunoglobulin G transport.

American journal of obstetrics and gynecology·1994
Same author

Cytokeratins, smooth muscle actin and vimentin in human normal salivary gland and pleomorphic adenomas. Immunohistochemical studies with particular reference to myoepithelial and basal cells.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·1991
Same author

Experimental radioimmunotherapy of HeLa tumours in nude mice with 131I-labeled monoclonal antibodies.

Anticancer research·1990

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Cytokeratins (CKs) are intermediate filament proteins crucial for cellular structural integrity.
  • Epithelial cells express specific CK profiles, which are generally maintained during malignant transformation.
  • This stability makes CKs effective histological tumor markers, particularly for poorly classified tumors.

Purpose of the Study:

  • To highlight the role of cytokeratins as biomarkers in cancer.
  • To discuss the utility of specific cytokeratins (CK 8, 18, 19) and tissue polypeptide antigen (TPA) in cancer diagnostics and patient follow-up.

Main Methods:

  • Review of existing literature on cytokeratin structure, expression, and function.
  • Analysis of cytokeratin release into tumor microenvironments and circulation.
  • Discussion of TPA as a serological marker derived from CK 8, 18, and 19.

Main Results:

  • Cytokeratin patterns are conserved during epithelial cell transformation to malignancy.
  • CK 8, 18, and 19 are abundant in carcinomas and are released into necrotic areas and blood.
  • Tissue polypeptide antigen (TPA), a complex of CK 8, 18, and 19, is a useful serological marker for cancer patient monitoring.

Conclusions:

  • Cytokeratins serve as reliable histological tumor markers due to conserved expression patterns.
  • Circulating cytokeratin complexes, including TPA, are valuable for serological cancer detection and follow-up.
  • Tumor-associated cytokeratins are potential targets for radioimmunodetection and immunotherapy.

Related Experiment Videos